The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer
Authors
Keywords
Colorectal cancer, Chemotherapy, Lymphopenia, Neutropenia, Prognosis
Journal
BMC CANCER
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-04-03
DOI
10.1186/1471-2407-13-177
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer
- (2011) Joji Kitayama et al. BMC CANCER
- Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy
- (2011) N. Cézé et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Interleukin-7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer
- (2011) Jian Ming et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Editorial [Hot Topic: Targeting the Microenvironment in Hematological Malignancies: How to Condition both Stromal and Effector Cells to Overcome Cancer Spreading(Guest Editors: Maria Raffaella Zocchi and Alessandro Poggi)]
- (2011) Maria Raffaella Zocchi et al. CURRENT MEDICINAL CHEMISTRY
- Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy
- (2011) Yu Ri Kim et al. Journal of Hematology & Oncology
- Bone invading NSCLC cells produce IL-7: mice model and human histologic data
- (2010) Ilaria Roato et al. BMC CANCER
- Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study
- (2010) Oscar Arrieta et al. BMC CANCER
- Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis
- (2010) A Dufresne et al. BRITISH JOURNAL OF CANCER
- Étude du profil immunitaire de sujets âgés hospitalisés en unité de court séjour gériatrique
- (2010) E. Crétel et al. REVUE DE MEDECINE INTERNE
- Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas
- (2009) Isabelle Ray-Coquard et al. CANCER RESEARCH
- Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: A mechanism of lymphangiogenesis in lung cancer
- (2009) Jian Ming et al. EUROPEAN JOURNAL OF CANCER
- Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma
- (2009) Lara Cattaruzza et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating levels of cobalt and chromium from metal-on-metal hip replacement are associated with CD8+ T-cell lymphopenia
- (2009) A. J. Hart et al. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- Study of lymphocyte subpopulations in bone marrow in a model of protein–energy malnutrition
- (2009) Ricardo Ambrósio Fock et al. NUTRITION
- Pharmacogenomics and -genetics in colorectal cancer
- (2008) Alexandra Pohl et al. ADVANCED DRUG DELIVERY REVIEWS
- Cancer survival in five continents: a worldwide population-based study (CONCORD)
- (2008) Michel P Coleman et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now